Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study
Authors:
- Emily A. LeesELEmily A. Lees
- Thomas C. WilliamsTWThomas C. Williams
- Robin MarlowRMRobin Marlow
- Felicity FitzgeraldFFFelicity Fitzgerald
- Christine JonesCJChristine Jones
- Hermione LyallHLHermione Lyall
- Alasdair BamfordABAlasdair Bamford
- Louisa PollockLPLouisa Pollock
- Andrew SmithASAndrew Smith
- Theresa LamagniTLTheresa Lamagni
- Alison KentAKAlison Kent
Open Access
- 9 August 2024
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 43 (9) , 841-850
Abstract
Background: During autumn/winter 2022, UK pediatricians reported an unseasonal increase in invasive group A streptococcal infections; a striking proportion presenting with pneumonia with parapneumonic effusion. Methods: Clinicians across the United Kingdom were requested to submit pseudonymized clinical data using a standardized report form for children (<16 years) admitted between September 30, 2022 and February 17, 2023, with microbiologically confirmed group A streptococcal pneumonia with parapneumonic effusion. Results: From 185 cases submitted, the median patient age was 4.4 years, and 163 (88.1%) were previously healthy. Respiratory viral coinfection was detected on admission for 101/153 (66.0%) children using extended respiratory pathogen polymerase chain reaction panel. Molecular testing was the primary method of detecting group A streptococcus on pleural fluid (86/171; 50.3% samples). Primary surgical management was undertaken in 171 (92.4%) children; 153/171 (89.4%) had pleural drain inserted (96 with fibrinolytic agent), 14/171 (8.2%) had video-assisted thoracoscopic surgery. Fever duration after admission was prolonged (median, 12 days; interquartile range, 9–16). Intravenous antibiotic courses varied in length (median, 14 days; interquartile range, 12–21), with many children receiving multiple broad-spectrum antibiotics, although evidence for additional bacterial infection was limited. Conclusions: Most cases occurred with viral coinfection, a previously well-recognized risk with influenza and varicella zoster, highlighting the need to ensure routine vaccination coverage and progress on vaccines for other common viruses (eg, respiratory syncytial virus, human metapneumovirus) and for group A streptococcus. Molecular testing is valuable to detect viral coinfection and confirm invasive group A streptococcal diagnosis, expediting the incorporation of cases into national reporting systems. Range and duration of intravenous antibiotics administered demonstrated the need for research on the optimal duration of antimicrobials and improved stewardship.Keywords
This publication has 34 references indexed in Scilit:
- Surge of lower respiratory tract group A streptococcal infections in England in winter 2022: epidemiology and clinical profileThe Lancet, 2023
- The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology studyClinical Microbiology and Infection, 2023
- Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in FranceJAMA Network Open, 2022
- Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UKThe Lancet Microbe, 2022
- Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010–2017: a nationwide surveillance studyClinical Microbiology and Infection, 2019
- Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelinesThe Lancet Infectious Diseases, 2016
- Treating invasive Group A Streptococcal infectionsPaediatrics and Child Health, 2014
- Increased incidence of bronchopulmonary fistulas complicating pediatric pneumoniaPediatric Pulmonology, 2011
- The epidemiology of hospitalized children with pneumococcal/lobar pneumonia and empyema from 1997 to 2004 in TaiwanEuropean Journal of Pediatrics, 2010
- The global burden of group A streptococcal diseasesThe Lancet Infectious Diseases, 2005